Fifteen-year-old Heman Bekele has garnered attention for his innovative work in potentially treating and preventing skin cancer. Originally from Ethiopia, Bekele’s interest in the effects of sun exposure on the skin developed at a young age. After moving to the U.S., his passion for chemistry was sparked when he received a chemistry set as a Christmas gift at the age of seven. This early introduction to science led him to explore the research surrounding skin cancer.
The Birth of a Groundbreaking Idea
Heman Bekele
Bekele’s innovation revolves around a soap infused with nanoparticles containing the drug imiquimod, which is already used to treat certain forms of skin cancer. His soap is designed to deliver the drug at a molecular level, ensuring it stays on the skin even after washing. This approach could make treatment more accessible and affordable, offering a significant alternative to the expensive cream currently available on the market.
Recognition and Future Endeavors- Heman Bekele
Heman Bekele
Bekele’s work has been recognized by the scientific community, winning him the 2023 Young Scientist Challenge and a $25,000 prize. He continues his research at the Johns Hopkins Bloomberg School of Public Health, where he collaborates with molecular biologist Vito Rebecca. While it may take up to a decade for the soap to be approved as a treatment, Bekele remains dedicated to his work, balancing his research with school and hobbies like playing in the marching band and chess.
A Potential Game-Changer for Skin Cancer Treatment
Heman Bekele’s innovative approach and unwavering commitment to his research hold the potential to revolutionize skin cancer treatment, especially for underserved communities. His journey from a curious child in Ethiopia to a young scientist on the brink of a medical breakthrough is a power of passion and perseverance.
